The Valley Desk

Clinical trial reportInternational journal of radiation oncology, biology, physicsPublished

A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
International journal of radiation oncology, biology, physics
Published
Subject terms
Humans; Head and Neck Neoplasms; Nausea; Cisplatin; Pyridazines; Quinazolines; DNA; Antineoplastic Combined Chemotherapy Protocols; Tablets; Protein Kinase Inhibitors
PubMed ID
37751793
Added to directory
Source checked

Report a correction or request removal